These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Estradiol and progesterone receptors in breast cancer: prognostic value after relapse.
    Author: Bonneterre J, Horner D, Peyrat JP, Vandewalle B, Cambier L, Demaille A.
    Journal: Breast Cancer Res Treat; 1985; 5(2):149-54. PubMed ID: 4016280.
    Abstract:
    The prognostic significance of estradiol (ER) and progesterone receptors (PgR) for survival from relapse has been studied in two groups of breast cancer patients: group 1, 35 patients in whom receptor levels were measured at the time of mastectomy; group II, 49 patients in whom receptor levels were measured at the time of recurrence. ER+ (greater than 10 fmoles/mg) patients had a better survival from relapse than ER- patients. High levels of PgR (greater than 50 fmoles/mg) had a prognostic significance only in group II patients.
    [Abstract] [Full Text] [Related] [New Search]